The Biotech Investor's Bible

ISBN-13: 9780471412793 / Angielski / Twarda / 2001 / 336 str.

George Wolff

Opis

A one-stop source for investing in biotech-with detailed coverage of the science, the business, the players, and the strategies for one of today's most promising (and volatile) industries
To invest in biotech is to invest in the future, and as such, investors need to learn the nuances of the science they're putting their money on. The core asset of biotech companies is knowledge, and sound investment decisions are impossible without an understanding of this complex science. That's where The Biotech Investor's Bible fits in. This much-needed, one-of-a-kind resource simplifies the complex science surrounding the business of biotech and clarifies subtle distinctions within the context of their financial repercussions. The book explains the basics of genetics, patents, and therapies; and teaches investors how to value biotech companies and their state-of-the art products and technology. The Biotech Investor's Bible offers an informative summary of the relatively short history of the industry and provides a comprehensive review of various industry sectors.
George Wolff (St. Pete Beach, FL) is a successful consultant advising clients who are investing in biotech stocks. He has assessed well over 150 biotech companies and has issued a number of valuable white papers that have charted the success of the hottest biotech companies.

Spis treści

PART I.

Introduction.

On the Threshold.

Assessing the Biotech Market.

The Keys to Biotech Investing.

Going Over Biotech Books.

The Four Tiers of Biotech Companies.

Biotechnology and Portfolio Planning.

Decision Making.

The Sector in Perspective.

The Biotech Investor′s Checklist.

PART II.

The Science Behind the Industry.

The Language of Genes.

The Realms of Biotechnology (or Who′s Doing What).

The Pick and Shovels of Biotechnology.

The New Biotech Therapies.

Special Sectors.

Appendix A: A Breakdown of 185 Major Biotech Companies.

Appendix B: Resources.

Appendix C: A Glossary of Terms.

Notes.

Index.

O autorze

GEORGE WOLFF is an award–winning journalist and, currently, a private business consultant to several firms in the investment industry. He has assessed and reported on more than 200 biotechnology companies for his clientele, issuing a number of valuable white papers charting the emergence of biotechnology. Previously, as a journalist, Wolff worked internationally covering the onset of the AIDS epidemic, the emergence of recombinant DNA technology, and the extraordinary stock market events of the previous twenty years. Wolff can be contacted through his web site, BioWolff.com.

Blurb

The complete guide to investing in the biotech industry

"Clear, never condescending, and with abundant references to biotech firms and their work in progress, The Biotech Investor′s Bible is a book that had to be written. Essential for the investor, fascinating even for armchair students of the industry, it′s a valuable reference, a guide to what is coming, and an irresistible read . . . it will be a definitive reference in the field."––Andrew Allentuck, globetechnology.com

"The Biotech Investor′s Bible outlines sensibly and with balance the opportunities and challenges of an industry that will change our lives. A must read guide for the individual investor."––William A. Haseltine, Ph.D., Chairman, CEO, and Founder, Human Genome Sciences, Inc., Editor–in–chief, E–Biomed: The Journal of Regenerative Medicine

Investors with a practical understanding of biotechnology share a remarkable opportunity: the chance to invest in an industry on the threshold of tremendous growth. With the long–term potential to cure most major diseases and to revolutionize industries as diverse as pharmaceuticals and forestry, petrochemicals and agriculture, the possibilities for biotech––and its investors––are limitless.

The Biotech Investor′s Bible provides you with the strategies and proven techniques to reduce risk and increase returns, including:
∗ The steps you must know in order to assess the biotech market ?
∗ A comprehensive look at 185 major biotech companies ?
∗ Guidelines to follow when planning your biotech portfolio ?
∗ An overview of the latest biotech therapies and breakthroughs ?
∗ Tips on how to find sound and promising companies in the sector ?
∗ An easy–to–understand introduction to the science and technology in the field ?